1	Ciba-Geigy	_	NNP	_	_	2	NAME	_	_
2	AG	_	NNP	_	_	10	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	the	_	DT	_	_	8	NMOD	_	_
5	big	_	JJ	_	_	8	NMOD	_	_
6	Swiss	_	JJ	_	_	8	NMOD	_	_
7	chemicals	_	NNS	_	_	8	NMOD	_	_
8	company	_	NN	_	_	2	APPO	_	_
9	,	_	,	_	_	2	P	_	_
10	said	_	VBD	_	_	0	ROOT	_	_
11	that	_	IN	_	_	10	OBJ	_	_
12	it	_	PRP	_	_	13	SBJ	_	_
13	agreed	_	VBD	_	_	11	SUB	_	_
14	in	_	IN	_	_	13	LOC	_	_
15	a	_	DT	_	_	16	NMOD	_	_
16	letter	_	NN	_	_	14	PMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	intent	_	NN	_	_	17	PMOD	_	_
19	with	_	IN	_	_	13	ADV	_	_
20	Corning	_	NNP	_	_	19	PMOD	_	_
21	Inc.	_	NNP	_	_	20	POSTHON	_	_
22	to	_	TO	_	_	13	OPRD	_	_
23	acquire	_	VB	_	_	22	IM	_	_
24	Corning	_	NNP	_	_	28	NMOD	_	_
25	's	_	POS	_	_	24	SUFFIX	_	_
26	50	_	CD	_	_	27	AMOD	_	_
27	%	_	NN	_	_	28	NMOD	_	_
28	share	_	NN	_	_	23	OBJ	_	_
29	of	_	IN	_	_	28	NMOD	_	_
30	Ciba	_	NNP	_	_	32	NAME	_	_
31	Corning	_	NNP	_	_	32	NAME	_	_
32	Diagnostics	_	NNPS	_	_	29	PMOD	_	_
33	Corp.	_	NNP	_	_	32	POSTHON	_	_
34	,	_	,	_	_	32	P	_	_
35	based	_	VBN	_	_	32	APPO	_	_
36	in	_	IN	_	_	35	LOC	_	_
37	Medfield	_	NNP	_	_	36	PMOD	_	_
38	,	_	,	_	_	37	P	_	_
39	Mass	_	NNP	_	_	37	APPO	_	_
40	.	_	.	_	_	10	P	_	_

1	Ciba	_	NNP	_	_	2	NAME	_	_
2	Corning	_	NNP	_	_	16	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	which	_	WDT	_	_	5	SBJ	_	_
5	had	_	VBD	_	_	2	NMOD	_	_
6	been	_	VBN	_	_	5	VC	_	_
7	a	_	DT	_	_	9	NMOD	_	_
8	50-50	_	JJ	_	_	9	NMOD	_	_
9	venture	_	NN	_	_	6	PRD	_	_
10	between	_	IN	_	_	9	NMOD	_	_
11	Basel-based	_	JJ	_	_	12	NMOD	_	_
12	Ciba-Geigy	_	NNP	_	_	10	PMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	Corning	_	NNP	_	_	13	CONJ	_	_
15	,	_	,	_	_	2	P	_	_
16	has	_	VBZ	_	_	27	OBJ	_	_
17	annual	_	JJ	_	_	18	NMOD	_	_
18	sales	_	NNS	_	_	16	OBJ	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	about	_	RB	_	_	21	DEP	_	_
21	$	_	$	_	_	19	PMOD	_	_
22	300	_	CD	_	_	21	DEP	_	_
23	million	_	CD	_	_	21	DEP	_	_
24	,	_	,	_	_	27	P	_	_
25	the	_	DT	_	_	26	NMOD	_	_
26	announcement	_	NN	_	_	27	SBJ	_	_
27	said	_	VBD	_	_	0	ROOT	_	_
28	.	_	.	_	_	27	P	_	_

1	Terms	_	NNS	_	_	5	SBJ	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	transaction	_	NN	_	_	2	PMOD	_	_
5	were	_	VBD	_	_	0	ROOT	_	_
6	n't	_	RB	_	_	5	ADV	_	_
7	disclosed	_	VBN	_	_	5	VC	_	_
8	.	_	.	_	_	5	P	_	_

1	Ciba	_	NNP	_	_	2	NAME	_	_
2	Corning	_	NNP	_	_	3	SBJ	_	_
3	makes	_	VBZ	_	_	0	ROOT	_	_
4	clinical	_	JJ	_	_	6	NMOD	_	_
5	diagnostics	_	NNS	_	_	6	NMOD	_	_
6	systems	_	NNS	_	_	3	OBJ	_	_
7	and	_	CC	_	_	6	COORD	_	_
8	related	_	JJ	_	_	9	NMOD	_	_
9	products	_	NNS	_	_	7	CONJ	_	_
10	for	_	IN	_	_	6	NMOD	_	_
11	the	_	DT	_	_	13	NMOD	_	_
12	medical-care	_	NN	_	_	13	NMOD	_	_
13	industry	_	NN	_	_	10	PMOD	_	_
14	.	_	.	_	_	3	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	announcement	_	NN	_	_	3	SBJ	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	acquisition	_	NN	_	_	6	SBJ	_	_
6	should	_	MD	_	_	3	OBJ	_	_
7	be	_	VB	_	_	6	VC	_	_
8	completed	_	VBN	_	_	7	VC	_	_
9	by	_	IN	_	_	8	TMP	_	_
10	December	_	NNP	_	_	9	PMOD	_	_
11	after	_	IN	_	_	8	TMP	_	_
12	a	_	DT	_	_	14	NMOD	_	_
13	definitive	_	JJ	_	_	14	NMOD	_	_
14	agreement	_	NN	_	_	15	SBJ	_	_
15	is	_	VBZ	_	_	11	SUB	_	_
16	completed	_	VBN	_	_	15	VC	_	_
17	and	_	CC	_	_	15	COORD	_	_
18	regulatory	_	JJ	_	_	19	NMOD	_	_
19	approval	_	NN	_	_	20	SBJ	_	_
20	is	_	VBZ	_	_	17	CONJ	_	_
21	received	_	VBN	_	_	20	VC	_	_
22	.	_	.	_	_	3	P	_	_

1	Ciba-Geigy	_	NNP	_	_	2	SBJ	_	_
2	intends	_	VBZ	_	_	0	ROOT	_	_
3	to	_	TO	_	_	2	OPRD	_	_
4	develop	_	VB	_	_	3	IM	_	_
5	the	_	DT	_	_	8	NMOD	_	_
6	Ciba	_	NNP	_	_	8	NMOD	_	_
7	Corning	_	NNP	_	_	8	NMOD	_	_
8	unit	_	NN	_	_	4	OBJ	_	_
9	into	_	IN	_	_	4	ADV	_	_
10	a	_	DT	_	_	13	NMOD	_	_
11	``	_	``	_	_	13	P	_	_
12	substantial	_	JJ	_	_	13	NMOD	_	_
13	business	_	NN	_	_	9	PMOD	_	_
14	,	_	,	_	_	4	P	_	_
15	''	_	''	_	_	4	P	_	_
16	making	_	VBG	_	_	4	ADV	_	_
17	the	_	DT	_	_	18	NMOD	_	_
18	unit	_	NN	_	_	16	OBJ	_	_
19	an	_	DT	_	_	22	NMOD	_	_
20	``	_	``	_	_	22	P	_	_
21	integral	_	JJ	_	_	22	NMOD	_	_
22	part	_	NN	_	_	16	OPRD	_	_
23	''	_	''	_	_	22	P	_	_
24	of	_	IN	_	_	22	NMOD	_	_
25	Ciba-Geigy	_	NNP	_	_	31	NMOD	_	_
26	's	_	POS	_	_	25	SUFFIX	_	_
27	``	_	``	_	_	31	P	_	_
28	comprehensive	_	JJ	_	_	31	NMOD	_	_
29	disease	_	NN	_	_	31	NMOD	_	_
30	management	_	NN	_	_	31	NMOD	_	_
31	concept	_	NN	_	_	24	PMOD	_	_
32	.	_	.	_	_	2	P	_	_

